![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
The item has been added to your shopping cart.
Home » Supreme Court Rejects Generic Challenge to Otsuka’s Abilify Patent
Supreme Court Rejects Generic Challenge to Otsuka’s Abilify Patent
January 16, 2013
The U.S. Supreme Court on refused to consider a generic-drug maker’s challenge to Otsuka Pharmaceutical’s U.S. patent for the blockbuster antipsychotic drug Abilify (aripiprazole).
Fox Business
Fox Business
Upcoming Events
-
21Oct